Despite guidance in a 2015 publication from international experts in immunohematology and transfusion medicine, many clinicians and laboratorians have yet to integrate RHD genotyping into routine practice when a patient's RhD serologic typing is weaker than expected. In this interview, international immunohematology expert Sue Johnson shows us how we can do better!

NOTE: CE credit has expired for this episode.